{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:42:00Z","timestamp":1778002920044,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016337","name":"Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education","doi-asserted-by":"publisher","award":["KLCCB-KF202304"],"award-info":[{"award-number":["KLCCB-KF202304"]}],"id":[{"id":"10.13039\/501100016337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013314","name":"Higher Education Discipline Innovation Project","doi-asserted-by":"publisher","award":["111-2-06"],"award-info":[{"award-number":["111-2-06"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2023682"],"award-info":[{"award-number":["BE2023682"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijbiomac.2025.150024","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:53:57Z","timestamp":1767113637000},"page":"150024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Modular pentameric protein scaffold based on glutaraldehyde-crosslinked Stx1B for superior multivalent therapeutics"],"prefix":"10.1016","volume":"339","author":[{"given":"Ronglian","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yating","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haofei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland J.","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2025.150024_bb0005","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1038\/s41467-020-18603-5","article-title":"Combinatorial entropy behaviour leads to range selective binding in ligand-receptor interactions","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.150024_bb0010","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.bpj.2022.04.017","article-title":"Modulating binding affinity, specificity, and configurations by multivalent interactions","volume":"121","author":"Deng","year":"2022","journal-title":"Biophys. J."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.150024_bb0015","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1002\/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3","article-title":"Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors","volume":"37","author":"Mammen","year":"1998","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.150024_bb0020","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/jacs.8b09198","article-title":"Multivalent ligand binding to cell membrane antigens: defining the interplay of affinity, valency, and expression density","volume":"141","author":"Csizmar","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.150024_bb0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40259-025-00720-6","article-title":"Understanding IgM structure and biology to engineer new antibody therapeutics","volume":"39","author":"Buchner","year":"2025","journal-title":"BioDrugs"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.150024_bb0030","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41423-023-01074-1","article-title":"Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection","volume":"20","author":"Pinho","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.150024_bb0035","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/jacs.8b10736","article-title":"Binding of the bacterial adhesin FimH to its natural, multivalent high-mannose type glycan targets","volume":"141","author":"Sauer","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.150024_bb0040","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1021\/acs.jmedchem.9b00303","article-title":"Enhanced inhibition of influenza a virus adhesion by di- and trivalent hemagglutinin inhibitors","volume":"62","author":"Lu","year":"2019","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.150024_bb0045","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.1021\/acs.jmedchem.1c00152","article-title":"Fighting Shigella by blocking its disease-causing toxin","volume":"64","author":"Haksar","year":"2021","journal-title":"J. Med. Chem."},{"issue":"32","key":"10.1016\/j.ijbiomac.2025.150024_bb0050","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.1002\/anie.201404397","article-title":"A protein-based pentavalent inhibitor of the cholera toxin B-subunit","volume":"53","author":"Branson","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.150024_bb0055","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1158\/1078-0432.CCR-23-0974","article-title":"Preclinical characterization and phase I trial results of INBRX-109, a third-generation, recombinant, humanized, death receptor 5 agonist antibody, in chondrosarcoma","volume":"29","author":"Subbiah","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijbiomac.2025.150024_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102834","article-title":"Compact clustering of highly oligomerized anti-DR5 nanobodies effectively drives apoptotic cancer cell death, significantly suppressing tumor growth","volume":"65","author":"Kim","year":"2025","journal-title":"Nano Today"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.150024_bb0065","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1535-7163.MCT-20-1132","article-title":"Multimeric anti-DR5 IgM agonist antibody IGM-8444 is a potent inducer of cancer cell apoptosis and synergizes with chemotherapy and BCL-2 inhibitor ABT-199","volume":"20","author":"Wang","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.150024_bb0070","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/bloodadvances.2020003731","article-title":"Potent preclinical activity of HexaBody-DR5\/DR5 in relapsed and\/or refractory multiple myeloma","volume":"5","author":"van der Horst","year":"2021","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.150024_bb0075","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1038\/s41467-021-23825-2","article-title":"Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers","volume":"12","author":"Rujas","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.150024_bb0080","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2212415","article-title":"Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2","volume":"15","author":"Verstraete","year":"2023","journal-title":"MAbs"},{"issue":"646","key":"10.1016\/j.ijbiomac.2025.150024_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn1252","article-title":"Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice","volume":"14","author":"Hunt","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.150024_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12951-024-02329-3","article-title":"Computational design and engineering of self-assembling multivalent microproteins with therapeutic potential against SARS-CoV-2","volume":"22","author":"Qin","year":"2024","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.150024_bb0095","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.tibs.2010.02.003","article-title":"Structure, biological functions and applications of the AB5 toxins","volume":"35","author":"Beddoe","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.150024_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.engmic.2023.100104","article-title":"The diverse landscape of AB5-type toxins","volume":"3","author":"Brown","year":"2023","journal-title":"Eng Microbiol"},{"key":"10.1016\/j.ijbiomac.2025.150024_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174057","article-title":"Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer","volume":"899","author":"Mohseni","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.150024_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141896","article-title":"A Shiga toxin B-subunit-based lectibody boosts T cell cytotoxicity towards Gb3-positive cancer cells","volume":"12","author":"Tomisch","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.150024_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrmicro2279","article-title":"Shiga toxins\u2014from cell biology to biomedical applications","volume":"8","author":"Johannes","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.150024_bb0120","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1021\/ac500926f","article-title":"Shiga-like toxin B subunit of Escherichia coli as scaffold for high-avidity display of anti-immunocomplex peptides","volume":"86","author":"Lassabe","year":"2014","journal-title":"Anal. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.150024_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015153","article-title":"Molecular basis of differential B-pentamer stability of Shiga toxins 1 and 2","volume":"5","author":"Conrady","year":"2010","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.150024_bb0130","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jasms.2005.07.016","article-title":"Stability of the homopentameric B subunits of shiga toxins 1 and 2 in solution and the gas phase as revealed by nanoelectrospray fourier transform ion cyclotron resonance mass spectrometry","volume":"16","author":"Kitova","year":"2005","journal-title":"J. Am. Soc. Mass Spectrom."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.150024_bb0135","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1016\/j.xphs.2022.07.017","article-title":"Repurposing the pentameric B-subunit of Shiga toxin for Gb3-targeted immunotherapy of colorectal cancer by rhamnose conjugation","volume":"111","author":"Liu","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"6515","key":"10.1016\/j.ijbiomac.2025.150024_bb0140","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.abd9909","article-title":"De novo design of picomolar SARS-CoV-2 miniprotein inhibitors","volume":"370","author":"Cao","year":"2020","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.ijbiomac.2025.150024_bb0145","doi-asserted-by":"crossref","first-page":"16758","DOI":"10.1021\/ja904698q","article-title":"Thermodynamic and structural effects of conformational constraints in protein-ligand interactions. Entropic paradoxy associated with ligand preorganization","volume":"131","author":"DeLorbe","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.150024_bb0150","doi-asserted-by":"crossref","DOI":"10.1063\/1.5027439","article-title":"Protein-ligand binding enthalpies from near-millisecond simulations: analysis of a preorganization paradox","volume":"149","author":"Li","year":"2018","journal-title":"J. Chem. Phys."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.150024_bb0155","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/cbic.201900251","article-title":"TRAIL-inspired multivalent dextran conjugates efficiently induce apoptosis upon DR5 receptor clustering","volume":"20","author":"Schneider","year":"2019","journal-title":"Chembiochem"},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.150024_bb0160","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1002\/anie.201511894","article-title":"An apoptosis-inducing Peptidic heptad that efficiently clusters death receptor\u00a05","volume":"55","author":"Valldorf","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.150024_bb0165","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/0008-5472.CAN-09-2889","article-title":"Multivalent DR5 peptides activate the TRAIL death pathway and exert tumoricidal activity","volume":"70","author":"Pavet","year":"2010","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.150024_bb0170","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1021\/acsbiomaterials.4c01412","article-title":"Glutaraldehyde cross-linking of salt-induced fibrinogen hydrogels","volume":"10","author":"Hense","year":"2024","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.ijbiomac.2025.150024_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2025.143740","article-title":"Glutaraldehyde cross-linking for improving the techno-functional properties of biopolymeric food packaging films; a comprehensive review","volume":"478","author":"Tavassoli","year":"2025","journal-title":"Food Chem."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025105813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025105813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:32:54Z","timestamp":1769506374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025105813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"alternative-id":["S0141813025105813"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.150024","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modular pentameric protein scaffold based on glutaraldehyde-crosslinked Stx1B for superior multivalent therapeutics","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.150024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150024"}}